Biological and JAK inhibitor therapy outcomes for severe psoriasis in trisomy 21. O'Connor C, Byrne B, Roche D, O'Connell G, et al. J Dermatol 2023 Jun 8. doi: 10.1111/1346-8138.16851.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

O'Connor C, Byrne B, Roche D, O'Connell G, et al. Biological and JAK inhibitor therapy outcomes for severe psoriasis in trisomy 21. J Dermatol 2023 Jun 8. doi: 10.1111/1346-8138.16851.
PMID: 37288481